Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Neptune Technologies & Bioressources Inc T.NTB

Sector: Healthcare | Sub-Sector: Biotechnology

Neptune Technologies & Bioressources Inc. is a biotechnology company engaged in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids.
Price: $2.51 | Change: $0.00 | % Change: 0.00%
Volume: 29,550 | Day High/Low: 2.55/2.50 | 52 Week High/Low: 4.35/2.41
top

Snapshot

Last Traded: April 23, 2014 09:05 Transaction Volume: 29,350
Open: $2.51 Previous Close: $2.51
Bid: $2.50 Ask: $2.51
Bid Size: 2,800 Ask Size: 200
Market Cap: $184.8m Shares Out: 73.6m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Latest News

Neptune Responds to Enzymotec's Continuous Attempts to Shift Focus From ITC Investigation

GlobeNewswire   1 day ago
0 stars

Neptune Technologies & Bioressources (T.NTB) shareholders push for change

Neptune Technologies & Bioressources (T.NTB) shareholder collective examines management changes in order to enhance share value

Stockhouse Editorial   12 days ago
0 stars

Shareholders of Neptune Technologies & Bioressources Inc. evaluate potential means to enhance shareholder value

Canada NewsWire   12 days ago
0 stars

Neptune Announces Closing of CAD$2.5 Million Private Placement

GlobeNewswire   April 4, 2014
0 stars

Neptune Technologies & Bioressources (T.NTB) dips 4% on patent litigation update

Neptune Technologies & Bioressources (T.NTB) provides patent litigation update with Enzymotec USA and shares slip 4%

Gaalen Engen   April 1, 2014
0 stars

Latest Bullboard Posts